Italy: leading active ingredients 2016, by level of public spending
This statistic shows the leading off patent active ingredients in Italy as of 2016, according to the level of public expenditure on them. As of 2016, the active ingredient with the highest value of public spending was Pantoprazole, with 184.28 million euros, followed by Atorvastatin with 145.21 million euros.